Institute for Myeloma & Bone Cancer Research Announces Publication in Targeted Oncology

Longest Survival Reported to Date for Multiple Myeloma Patients WEST HOLLYWOOD, Calif., Sept. 19, 2023 /PRNewswire/ — The Institute for Myeloma & Bone Cancer Research (IMBCR) announces the publication in Targeted Oncology on the outstanding survival of 161 unselected, new patients with…

Click here to view original post